Search results
A blood test to help detect lung cancer? New test offered at OSF Healthcare part of trend in...
Chicago Tribune via Yahoo News· 15 hours agoJulie Harris had never been tested for lung cancer. A low-dose CT scan, the only recommended ...
Tricare Lowers Age for Colon Cancer Screenings to 45
Military.com· 2 weeks agoTricare beneficiaries at average risk for colorectal cancer can now receive covered screening exams and lab tests five years sooner, at age 45, following...
Analyst Report: Exact Sciences Corporation
Morningstar Research via Yahoo Finance· 1 day agoExact’s Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer& ...
New Day Aims to Enter CRC Screening Market With Combined PCR, Immunoassay Test
GenomeWeb News· 4 days agoEDP had developed prior to the deal a multiplex immunoassay, ColoPlex, for the early detection of colorectal cancer and precancerous polyps. Later that month, New Day said ...
Geneoscopy Nabs FDA Approval for Stool-Based Colorectal Cancer Screening Test
GenomeWeb News· 3 days agoOncology diagnostics firm Geneoscopy said on Tuesday that the US Food and Drug Administration has approved its noninvasive, stool-based colorectal cancer screening ...
Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 days agoThe company's flagship product, Cologuard, is the first FDA-approved non-invasive stool-based DNA ...
It may be safe for some to wait 15 years for repeat colonoscopy, study suggests
NBC News via Yahoo News· 1 week agoNew research suggests average-risk patients may only need to get a colonoscopy for colorectal cancer...
Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by California Public Employees Retirement System
ETF DAILY NEWS· 2 weeks agoCalifornia Public Employees Retirement System lessened its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3.0% in the fourth quarter, according to the company in its ...
Analysts Set Exact Sciences Co. (NASDAQ:EXAS) PT at $97.44
ETF DAILY NEWS· 3 days agoExact Sciences Co. (NASDAQ:EXAS – Get Free Report) has received a consensus rating of “Moderate Buy” from the thirteen ratings firms that are presently covering the stock, MarketBeat.com reports ...
Van ECK Associates Corp Sells 9,078 Shares of Exact Sciences Co. (NASDAQ:EXAS)
ETF DAILY NEWS· 1 week agoVan ECK Associates Corp trimmed its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 6.1% in the 4th quarter, according to the company in its most recent Form 13F filing ...